← Open Payments lookup

DANIEL BREEYEAR: Open Payments

NPI 1922620178 · NISKAYUNA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$96,369 in 270 payments from 16 companies in 2025. Trend: 2023 $23,458 · 2024 $25,404 · 2025 $96,369

Speaker / faculty: $38,760Honoraria: $29,990Travel & lodging: $17,783Food & beverage: $6,648Consulting: $3,188
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)105$55,514
Axsome Therapeutics, Inc.87$38,725
Alkermes, Inc.10$529
Janssen Pharmaceuticals, Inc8$317
Otsuka America Pharmaceutical, Inc.13$296
Neurocrine BioSciences, Inc.17$276
ABBVIE INC.6$227
Lundbeck LLC6$124
Teva Pharmaceuticals USA, Inc.3$87
Supernus Pharmaceuticals, Inc.3$66

Products named: CAPLYTA, Auvelity, ARISTADA, REXULTI, INGREZZA, SPRAVATO, VRAYLAR, AUSTEDO XR.

Industry payments across NY — which companies pay providers there.